查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439276

神經診斷與監測設備 - 全球市場考量、競爭格局、市場預測 (2030)

Neurological Diagnostic and Monitoring Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球神經診斷和監測設備市場規模預計到2023年將達到118.1億美元，到2030年將達到173.3億美元，2024-2030年預測期間複合年增長率為6.66%。對神經診斷和監測設備的需求增加主要是由於神經系統疾病的盛行率不斷上升、老年人口的不斷增長、創傷性腦損傷的盛行率不斷增加、產品組合的技術進步、神經系統疾病和適當的技術進步推動了這一趨勢。政府加大努力，提高患者對早期診斷的認識，以便更好地進行管理。

神經診斷和監測設備的市場動態

由於全球癲癇、中風和帕金森氏症等神經系統疾病的盛行率不斷上升，全球神經系統診斷和監測設備市場的成長正在迅速加速。根據世界衛生組織（2022）的數據，癲癇是一種慢性腦部疾病，影響全球約5,000萬人，其中80%生活在低收入和中等收入國家，佔全球疾病負擔的很大一部分。據估計，透過正確的診斷和治療，70%的癲癇患者將不再癲癇發作。

此外，世界各地腦腫瘤和癌症的發生率正在上升。例如，根據全球癌症觀察站（2020）的統計，2020年全球新增腦腫瘤和中樞神經系統癌症病例308,102例。因此，患者數量的增加以及對這些疾病早期診斷的需求可能會增加對神經診斷和監測設備的需求，這有望進一步提振全球神經診斷和監測設備市場。

此外，利用先進技術的神經診斷設備的產品批准可能會快速成長全球神經診斷和監測設備市場。例如，最近在 2020 年 1 月，Compumedics Limited 的 Orion LifeSpanTM MEG 獲得美國 FDA 批准，該產品配備了專利 DROS;SQUID 感測器系統。

然而，缺乏熟練的專業人員以及手術和腦監測設備的高昂成本等某些因素是限制全球神經診斷和監測設備需求的主要因素，特別是在報銷政策較低的已開發國家。

神經診斷與監測設備市場細分分析

在神經診斷和監測設備產品領域，腦電圖（EEG）在預測期內將佔據很大的市場份額。這是因為獨立和便攜式 EEG 模型可提供各種通道，例如 8、21、25 和 32。此外，促進腦電圖領域成長的其他因素包括製造商更加關注技術進步，例如減輕重量、便攜性和同時收集原始數據。此外，臨床實踐和戶外研究對便攜式設備的需求不斷增加預計將促進該領域的成長。

最近，2019 年，Nihon Kohden 推出了 VitalEEG(TM)，快速評估昏迷患者的大腦健康狀況。該系統提供遠端存取功能，允許臨床醫生從醫院內的任何地方評估關鍵訊息，以及藍牙通信，無需額外的電纜。

預計此類產品的推出也將在預測期內推動神經診斷和監測設備市場的細分市場成長。

北美預計將主導整個神經診斷和監測設備市場

預計在預測期內，北美將主導整個神經診斷和監測設備市場。這一優勢是由於創傷性腦損傷 (TBI) 的盛行率不斷上升、醫療成本不斷上升以及該地區擁有發達且先進的醫療保健系統。此外，適當的報銷政策也是一個驅動因素。

例如，根據 CDC 2022 年報告，2019 年美國約有 61,000 人因 TBI 相關死亡。研究也估計，美國約有 170 萬人遭受創傷性腦損傷，其中 15 歲至 19 歲的青少年和 65 歲以上的成年人遭受創傷性腦損傷的風險最高。

本報告研究和分析了全球神經診斷和監測設備市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第1章 神經診斷及監護設備報告簡介

第2章 神經診斷與監測設備摘要

  • 調查範圍
  • 市場概況
  • 競爭評估

第3章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章 神經診斷與監護設備市場關鍵因素分析

  • 神經診斷和監測設備市場的驅動因素
    • 隨著人口老化的加劇，神經系統疾病的盛行率不斷增加
    • 創傷性腦損傷的盛行率增加
    • 我們產品組合的技術進步
    • 政府加強提高患者對神經系統疾病的認識以及早期診斷以進行適當的治療
  • 神經診斷和監測設備市場的抑制因素和挑戰
    • 設備和流程成本高
    • 熟練工人短缺
  • 神經診斷和監測設備市場的機會
    • 對非侵入式設備的需求不斷增長
    • 發展中國家的市場成長機會

第5章 神經診斷監測設備的波特五力分析

第6章 神經診斷及監護設備市場佈局

  • 按類型
    • 侵入性的
    • 非侵入性
  • 按產品類型
    • 腦磁圖設備（MEG）
    • 腦電圖設備（EEG）
    • 經顱多普勒超音波設備
    • 腦血氧儀
    • 顱內壓監測儀
    • 其他
  • 按指示
    • 癲癇
    • 創傷性腦損傷
    • 中風
  • 按最終用戶
    • 醫院
    • 診斷中心/影像中心
  • 按地區
    • 北美神經診斷與監測設備市場規模
    • 歐洲神經診斷與監測設備市場規模（2021-2030）
    • 亞太地區神經診斷與監測設備市場規模（2021-2030）
    • 其他地區神經診斷及監護設備市場規模（2021-2030年）

第7章 神經診斷及監護設備公司及產品簡介

  • Natus Medical, Inc
  • Nihon Kohden Corporation
  • Koninklijke Philips N.V.
  • Compumedics Limited
  • Croton Healthcare
  • Ricoh
  • Elekta AB
  • Integra LifeSciences
  • RAUMEDIC AG
  • Masimo
  • CadwellR Industries Inc.
  • Nonin
  • Neurosoft
  • Brain Scientific, Inc.
  • Recorders & Medicare Systems Pvt Ltd (RMS)
  • Rimed
  • Allengers
  • Medtronic
  • Edwards Lifesciences Corporation.
  • Ybrain, INC

第8章 KOL觀點

第9章 專案方法

第10章 DelveInsight服務內容

第11章 關於 DelveInsight

第12章 免責聲明與聯絡我們

Product Code: DIMDCL0066

Neurological Diagnostic and Monitoring Equipment Market By Type (Invasive and Non-Invasive), Product Type (Magneto-Encephalography Devices (Meg), Electroencephalography Devices (Eeg), Transcranial Doppler Sonography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, and Others), Indication (Traumatic Brain Injuries, Epilepsy, Stroke, and Others), End-User (Hospitals, Diagnostic & Imaging Centers, and Others), and Geography is expected to grow at a static CAGR forecast till 2030 due to advances in product portfolio and burgeoning neurological disorder prevalence among the aging population.

The global neurological diagnostic and monitoring equipment market was valued at USD 11.81 billion in 2023, growing at a CAGR of 6.66% during the forecast period from 2024 to 2030, and will reach USD 17.33 billion by 2030. The rise in demand for neurological diagnostic and monitoring equipment is primarily motivated by the increasing prevalence of neurological disorders along with the rising aging population, growing incidence of traumatic brain injuries, technological advancement in the product portfolio, the rising government initiatives to raise awareness among patient regarding neurological disorders and their early diagnosis for proper management, among others.

Neurological Diagnostic and Monitoring Equipment Market Dynamics:

The global neurological diagnostic and monitoring equipment market growth is burgeoning due to the rising prevalence of neurological disorders such as epilepsy, stroke, and Parkinson's among others across the globe. According to WHO 2022, epilepsy is a chronic brain disorder that accounts for a significant proportion of the world's disease burden by affecting around 50 million people across the globe with 80% of the cases in low and middle-income nations. Also, the report mentions that an estimated 70% of people with epilepsy could be seizure-free if properly diagnosed and treated.

Moreover, the incidence of brain tumors and cancer among the world population is also on the rise. For instance, as per the Global Cancer Observatory 2020 statistics, globally there were 308,102 new cases of brain and central nervous system cancer new cases in 2020. Therefore, the rising patient population and the need for early diagnosis of these disorders could increase the demand for neurodiagnostic and monitoring devices which further is expected to boost the global neurological diagnostic and monitoring equipment market.

Further, product approval of technologically advanced neurodiagnostic devices is likely to upsurge the global neurological diagnostic and monitoring equipment market. For example, recently in January 2020, Compumedics Limited received US FDA approval for Orion LifeSpanTM MEG with a patented double relaxation oscillator superconducting quantum interference device (DROS; SQUID) sensor system.

However, certain factors such as the dearth of skilled professionals and the high cost of surgery and devices for brain monitoring are major factors limiting the global demand for neurological diagnostic and monitoring equipment, especially in developed countries with low reimbursement policies.

Neurological Diagnostic and Monitoring Equipment Market Segment Analysis:

Neurological Diagnostic and Monitoring Equipment Market By Type (Invasive and Non-Invasive), Product Type (Magneto-Encephalography Devices (MEG), Electroencephalography Devices (EEG), Transcranial Doppler Sonography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, and Others), Indication (Traumatic Brain Injuries, Epilepsy, Stroke, and Others), End-User (Hospitals, Diagnostic & Imaging Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the neurological diagnostic and monitoring equipment product segment, electroencephalography devices (EEG) hold a significant market during the forecasted period. This is owing to the availability of standalone as well as portable EEG models with different channels such as 8, 21, 25, and 32, among others. Moreover, other factors that contribute to the growth of the EEG segment are the growing focus of manufacturers towards technological advancements, such as lightweight, portability, and the acquisition of raw data simultaneously. Also, the increasing demand for portable devices for clinical practice and outdoor investigation is projected to augment the segment growth.

Furthermore, recently in 2019, Nihon Kohden launched VitalEEG(TM) to rapidly assess brain health in unconscious patients. The system provides both remote access functionality, so clinicians can assess critical information from anywhere in the hospital, and Bluetooth communication, eliminating the need for additional cables.

Thus such product launches are also expected to fuel the segmental growth of the neurological diagnostic and monitoring equipment market during the forecasted period.

North America is expected to dominate the overall Neurological Diagnostic and Monitoring Equipment Market:

North America is expected to dominate the overall neurological diagnostic and monitoring equipment market during the forecast period. This domination is due growing incidence of traumatic brain injuries (TBI), the increased healthcare expenditure along with the presence of well-developed and advanced healthcare systems in the region. Moreover, adequate reimbursement policies are the driving factors.

For instance, as per the CDC 2022 report, in 2019, there were nearly 61,000 TBI-related deaths in the US. Also, research studies have estimated that in the US, approximately 1.7 million people suffer a traumatic brain injury, with adolescents between ages 15 and 19 and adults aged 65 and older among the most likely to sustain a traumatic brain injury.

The presence of key market players such as Masimo Corporation, Compumedics Limited, and Natus Medical Incorporated, among others in the region is likely to boost the neurological diagnostic and monitoring equipment market.

Moreover, an increase in product approval in the region is also a driving factor for the Neurological Diagnostic and Monitoring Equipment in the region. For instance, in August 2020, Masimo announced that O3® Regional Oximetry has received FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains.

Thus, the aforementioned factors are likely to upsurge the market for neurological diagnostic and monitoring equipment in the region.

Neurological Diagnostic and Monitoring Equipment Market Key Players:

Some of the key market players operating in the neurological diagnostic and monitoring equipment market include Natus Medical, Inc., Nihon Kohden Corporation, Koninklijke Philips N.V., Compumedics Limited, Croton Healthcare, Ricoh, Elekta AB, Integra LifeSciences, RAUMEDIC AG, Masimo, Cadwell® Industries Inc., Nonin, Neurosoft, Brain Scientific, Inc., Recorders & Medicare Systems Pvt Ltd (RMS), Rimed, Allengers, Medtronic, Edwards Lifesciences Corporation., Ybrain, INC, and others.

Recent Developmental Activities in the Neurological Diagnostic and Monitoring Equipment Market:

In March 2022, Brain Scientific received FDA Clearance for Next-Gen NeuroCap(TM) EEG Headset, an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in routine clinical and research settings where the recording of STAT EEGs is desired.

In October 2020, MEGIN announced Japan Expansion by launching MEGIN KK in Tokyo.

In December 2019, Raumedic, a medical technology manufacturer, launched a new home-use device, named Raumed Home ICP, for intracranial pressure (ICP) monitoring. The product was developed for patients suffering from hydrocephalus.

Key Takeaways from the Neurological Diagnostic and Monitoring Equipment Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global neurological diagnostic and monitoring equipment market.

Various opportunities available for the other competitor in the neurological diagnostic and monitoring equipment market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for neurological diagnostic and monitoring equipment market growth in the coming future?

Target Audience who can be benefited from Neurological Diagnostic and Monitoring Equipment Market Report Study

Neurological Diagnostic and Monitoring Equipment providers

Research organizations and consulting companies

Neurological Diagnostic and Monitoring Equipment-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in neurological diagnostic and monitoring equipment

Various End-Users who want to know more about the neurological diagnostic and monitoring equipment market and the latest technological developments in the neurological diagnostic and monitoring equipment market.

Frequently Asked Questions for Neurological Diagnostic and Monitoring Equipment Market:

1. What is Neurological Diagnostic and Monitoring Equipment?

Neurological Diagnostic and Monitoring Equipment are the devices used for the diagnosis of neurological disorders such as stroke, migraine, epilepsy, Parkinson's disease, and ischemic stroke, among others. There are various equipment available in the market such as EEG, MEG, Cerebral Oximeters, among others.

2. What is the market for global neurological diagnostic and monitoring equipment?

The global Neurological Diagnostic and Monitoring Equipment Market was valued at USD 11.81 billion in 2023, growing at a CAGR of 6.66% during the forecast period from 2024 to 2030, and will reach USD 17.33 billion by 2030.

3. What are the drivers for global neurological diagnostic and monitoring equipment?

The major factors driving the demand for Neurological Diagnostic and Monitoring Equipment are the growing prevalence of neurological disorders coupled with the rising geriatric population, the increasing incidence of traumatic brain injuries, and the launch of technically advanced products in the market.

4. Who are the key players operating in global neurological diagnostic and monitoring equipment?

Some of the key market players operating in the neurological diagnostic and monitoring equipment market include natus medical, inc., Nihon Kohden Corporation, Koninklijke Philips N.V., Compumedics Limited, Croton Healthcare, Ricoh, Elekta AB, Integra LifeSciences, RAUMEDIC AG, Masimo, Cadwell® Industries Inc., Nonin, Neurosoft, Brain Scientific, Inc., Recorders & Medicare Systems Pvt Ltd (RMS), Rimed, Allengers, Medtronic, Edwards Lifesciences Corporation., Ybrain, INC, and others.

5. Which region has the highest share in the neurological diagnostic and monitoring equipment market?

North America is expected to dominate the overall neurological diagnostic and monitoring equipment market during the forecast period, 2024-2030. this domination is because of the increased healthcare expenditure along with the presence of well-developed and advanced healthcare systems in the region. Moreover, adequate reimbursement policies are the driving factors.

Table of Contents

1. Neurological Diagnostic and Monitoring Equipment Report Introduction

2. Neurological Diagnostic and Monitoring Equipment Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Neurological Diagnostic and Monitoring Equipment Market Key Factors Analysis

  • 4.1. Neurological Diagnostic and Monitoring Equipment Market Drivers
    • 4.1.1. Increasing prevalence of neurological disorders coupled with the rising aging population
    • 4.1.2. Growing Incidence of Traumatic Brain Injuries
    • 4.1.3. Technological advancement in the product portfolio
    • 4.1.4. Rising government initiative to raise awareness among patients regarding neurological disorders and their early diagnosis for proper management
  • 4.2. Neurological Diagnostic and Monitoring Equipment Market Restraints and Challenges
    • 4.2.1. High cost of the devices and procedure
    • 4.2.2. The dearth of skilled labors
  • 4.3. Neurological Diagnostic and Monitoring Equipment Market Opportunities
    • 4.3.1. Growing demand for non-invasive devices
    • 4.3.2. Market growth opportunities in developing nations

5. Neurological Diagnostic and Monitoring Equipment Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Neurological Diagnostic and Monitoring Equipment Market Layout

  • 6.1. By Type
    • 6.1.1. Invasive
    • 6.1.2. Non-invasive
  • 6.2. By Product Type
    • 6.2.1. Magnetoencephalography Devices (MEG)
    • 6.2.2. Electroencephalography Devices (EEG)
    • 6.2.3. Transcranial Doppler Sonography Devices
    • 6.2.4. Cerebral Oximeters
    • 6.2.5. Intracranial Pressure Monitors
    • 6.2.6. Others
  • 6.3. By Indication
    • 6.3.1. Epilepsy
    • 6.3.2. Traumatic Brain Injuries
    • 6.3.3. Stroke
    • 6.3.4. Others
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostic & Imaging Centers
    • 6.4.3. Others
  • 6.5. By Geography
    • 6.5.1. North America Neurological Diagnostic and Monitoring Equipment Market Size in USD million 2021-2030)
      • 6.5.1.1. United States Neurological Diagnostic and Monitoring Equipment Market Size in USD million 2021-2030)
      • 6.5.1.2. Canada Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.1.3. Mexico Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
    • 6.5.2. Europe Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.1. France Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.2. Germany Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.4. Italy Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.5. Spain Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
    • 6.5.3. Asia-Pacific Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.1. China Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.2. Japan Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.3. India Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.4. Australia Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.5. South Korea Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia Pacific Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW) Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.4.1. Middle East Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.4.2. Africa Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.4.3. South America Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)

7. Neurological Diagnostic and Monitoring Equipment Company and Product Profiles

  • 7.1. Natus Medical, Inc
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Nihon Kohden Corporation
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Koninklijke Philips N.V.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Compumedics Limited
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Croton Healthcare
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Ricoh
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Elekta AB
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Integra LifeSciences
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. RAUMEDIC AG
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Masimo
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Cadwell® Industries Inc.
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Nonin
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Neurosoft
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Brain Scientific, Inc.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Recorders & Medicare Systems Pvt Ltd (RMS)
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. Rimed
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Allengers
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. Medtronic
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. Edwards Lifesciences Corporation.
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. Ybrain, INC
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Neurological Diagnostic and Monitoring Equipment Market in Global (2021-2030)
  • Table 3: Neurological Diagnostic and Monitoring Equipment Market in Global by Type (2021-2030)
  • Table 4: Neurological Diagnostic and Monitoring Equipment Market in Global by Product Type (2021-2030)
  • Table 5: Neurological Diagnostic and Monitoring Equipment Market in Global by Indication (2021-2030)
  • Table 6: Neurological Diagnostic and Monitoring Equipment Market in Global by End-User (2021-2030)
  • Table 7: Neurological Diagnostic and Monitoring Equipment Market in Global by Geography (2021-2030)
  • Table 8: Neurological Diagnostic and Monitoring Equipment Market in North America (2021-2030)
  • Table 9: Neurological Diagnostic and Monitoring Equipment Market in the US (2021-2030)
  • Table 10: Neurological Diagnostic and Monitoring Equipment Market in Canada (2021-2030)
  • Table 11: Neurological Diagnostic and Monitoring Equipment Market in Mexico (2021-2030)
  • Table 12: Neurological Diagnostic and Monitoring Equipment Market in Europe (2021-2030)
  • Table 13: Neurological Diagnostic and Monitoring Equipment Market in France (2021-2030)
  • Table 14: Neurological Diagnostic and Monitoring Equipment Market in Germany (2021-2030)
  • Table 15: Neurological Diagnostic and Monitoring Equipment Market in the United Kingdom (2021-2030)
  • Table 16: Neurological Diagnostic and Monitoring Equipment Market in Italy (2021-2030)
  • Table 17: Neurological Diagnostic and Monitoring Equipment Market in Spain (2021-2030)
  • Table 18: Neurological Diagnostic and Monitoring Equipment Market in Rest of Europe (2021-2030)
  • Table 19: Neurological Diagnostic and Monitoring Equipment Market in Asia-Pacific (2021-2030)
  • Table 20: Neurological Diagnostic and Monitoring Equipment Market in China (2021-2030)
  • Table 21: Neurological Diagnostic and Monitoring Equipment Market in Japan (2021-2030)
  • Table 22: Neurological Diagnostic and Monitoring Equipment Market in India (2021-2030)
  • Table 23: Neurological Diagnostic and Monitoring Equipment Market in Australia (2021-2030)
  • Table 24: Neurological Diagnostic and Monitoring Equipment Market in South Korea (2021-2030)
  • Table 25: Neurological Diagnostic and Monitoring Equipment Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Neurological Diagnostic and Monitoring Equipment Market in the Rest of the World (2021-2030)
  • Table 27: Neurological Diagnostic and Monitoring Equipment Market in the Middle East (2021-2030)
  • Table 28: Neurological Diagnostic and Monitoring Equipment Market in Africa (2021-2030)
  • Table 29: Neurological Diagnostic and Monitoring Equipment Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Neurological Diagnostic and Monitoring Equipment Market in Global (2021-2030)
  • Figure 3: Neurological Diagnostic and Monitoring Equipment Market in Global by Type (2021-2030)
  • Figure 4: Neurological Diagnostic and Monitoring Equipment Market in Global by Product Type (2021-2030)
  • Figure 5: Neurological Diagnostic and Monitoring Equipment Market in Global by Indication (2021-2030)
  • Figure 6: Neurological Diagnostic and Monitoring Equipment Market in Global by End-User (2021-2030)
  • Figure 7: Neurological Diagnostic and Monitoring Equipment Market in Global by Geography (2021-2030)
  • Figure 8: Neurological Diagnostic and Monitoring Equipment Market in North America (2021-2030)
  • Figure 9: Neurological Diagnostic and Monitoring Equipment Market in the US (2021-2030)
  • Figure 10: Neurological Diagnostic and Monitoring Equipment Market in Canada (2021-2030)
  • Figure 11: Neurological Diagnostic and Monitoring Equipment Market in Mexico (2021-2030)
  • Figure 12: Neurological Diagnostic and Monitoring Equipment Market in Europe (2021-2030)
  • Figure 13: Neurological Diagnostic and Monitoring Equipment Market in France (2021-2030)
  • Figure 14: Neurological Diagnostic and Monitoring Equipment Market in Germany (2021-2030)
  • Figure 15: Neurological Diagnostic and Monitoring Equipment Market in the United Kingdom (2021-2030)
  • Figure 16: Neurological Diagnostic and Monitoring Equipment Market in Italy (2021-2030)
  • Figure 17: Neurological Diagnostic and Monitoring Equipment Market in Spain (2021-2030)
  • Figure 18: Neurological Diagnostic and Monitoring Equipment Market in Rest of Europe (2021-2030)
  • Figure 19: Neurological Diagnostic and Monitoring Equipment Market in Asia-Pacific (2021-2030)
  • Figure 20: Neurological Diagnostic and Monitoring Equipment Market in China (2021-2030)
  • Figure 21: Neurological Diagnostic and Monitoring Equipment Market in Japan (2021-2030)
  • Figure 22: Neurological Diagnostic and Monitoring Equipment Market in India (2021-2030)
  • Figure 23: Neurological Diagnostic and Monitoring Equipment Market in Australia (2021-2030)
  • Figure 24: Neurological Diagnostic and Monitoring Equipment Market in South Korea (2021-2030)
  • Figure 25: Neurological Diagnostic and Monitoring Equipment Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Neurological Diagnostic and Monitoring Equipment Market in the Rest of the World (2021-2030)
  • Figure 27: Neurological Diagnostic and Monitoring Equipment Market in the Middle East (2021-2030)
  • Figure 28: Neurological Diagnostic and Monitoring Equipment Market in Africa (2021-2030)
  • Figure 29: Neurological Diagnostic and Monitoring Equipment Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER's Five Force Analysis